Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-kinase Inhibitors

Por Marlowe, Timothy A., Lenzo, Felicia L., Figel, Sheila A., Grapes, Abigail T., Cance, William G.
Publicado no Mol Cancer Ther (2016)

Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor β and AP-1 recruitment to adjacent promoter binding sites

Por Ivanova, Margarita M., Luken, Kristen H., Zimmer, Amber S., Lenzo, Felicia L., Smith, Ryan J., Arteel, Maia W., Kollenberg, Tara J., Mattingly, Kathleen A., Klinge, Carolyn M.
Publicado em 2011

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Por Morrison, Carl, Pabla, Sarabjot, Conroy, Jeffrey M., Nesline, Mary K., Glenn, Sean T., Dressman, Devin, Papanicolau-Sengos, Antonios, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Qin, Moachun, Wang, Yirong, Lenzo, Felicia L., Omilian, Angela, Bshara, Wiam, Zibelman, Matthew, Ghatalia, Pooja, Dragnev, Konstantin, Shirai, Keisuke, Madden, Katherine G., Tafe, Laura J., Shah, Neel, Kasuganti, Deepa, de la Cruz-Merino, Luis, Araujo, Isabel, Saenger, Yvonne, Bogardus, Margaret, Villalona-Calero, Miguel, Diaz, Zuanel, Day, Roger, Eisenberg, Marcia, Anderson, Steven M., Puzanov, Igor, Galluzzi, Lorenzo, Gardner, Mark, Ernstoff, Marc S.
Publicado no J Immunother Cancer (2018)